Intellectual Property

  • July 03, 2024

    Revived Skinny Label Case Is A Warning For Generics

    The Federal Circuit has made clear that generic-drug companies need to pay close attention to public statements when advertising drugs that still have patent-protected uses, even if their so-called skinny labels properly avoid references to those carved-out indications, attorneys say.

  • July 03, 2024

    Full Fed. Circ. Urged To Rethink Amazon Patent Program Case

    Lighting Defense Group has urged the full Federal Circuit to undo a decision that it must face a declaratory judgment suit in the home state of a company it accused of infringement through an Amazon patent program, saying the holding is in "intractable conflict" with precedent.

  • July 03, 2024

    Appeals Board Tosses Revived License Breach Dispute

    The Civilian Board of Contract Appeals has again tossed a dispute, previously revived by the Federal Circuit, alleging the U.S. Food and Drug Administration breached a software company's end-user license agreement, saying it lacks jurisdiction to enforce the agreement.

  • July 03, 2024

    Siemens, GlobalFoundries Kill Chip Design IP Under Alice

    Siemens and GlobalFoundries nabbed a major win Tuesday when a Delaware federal magistrate judge granted the semiconductor makers' summary judgment bids in a patent infringement case, holding that the chip design patents the companies are accused of infringing are invalid under Alice.

  • July 03, 2024

    Cooley DQ'd From IP Case Over Atty's Past Patent Work

    Cooley LLP was disqualified on Wednesday from representing a pharmaceutical customer-support software company against patent infringement claims in Delaware, with the district court citing a Cooley partner's prior work representing the plaintiff and Cooley's refusal to screen its attorney.

  • July 03, 2024

    Cardi B Accused Of Ripping Off FX Show's Song For Single

    Two music creators say Cardi B's new hit "Enough (Miami)" infringed a song they wrote in 2021, telling a Texas federal court Wednesday that they're entitled to a temporary and permanent restraining order barring the song from being played.

  • July 03, 2024

    Penile Implant Doc Seeks $7M Atty Fees, Costs In $18M IP Win

    A urologist who won $18.3 million in royalties and damages after a jury found a rival stole his penile implant trade secrets and infringed his intellectual property asked a California federal judge for $6.5 million in attorney fees and $614,000 in costs, saying he is owed the funds as the prevailing party in the litigation.

  • July 03, 2024

    Google Defeats Online Media Patent Suit At Fed. Circ.

    A Federal Circuit panel on Wednesday backed Google LLC's win in a California federal suit accusing it of infringing patents on creating layered web-based communications like ads and websites.

  • July 03, 2024

    Akerman Beats DQ Bid In Sneaker Product IP Battle

    Akerman LLP can't be disqualified from defending a manufacturing company against claims that it stole from a social media influencer it partnered with to sell sneaker care products, a California federal judge has ruled.

  • July 03, 2024

    Juul License Voids Vape Royalties For Altria, Reynolds Argues

    R.J. Reynolds Vapor Co. said it shouldn't have to pay royalties to the parent company of Philip Morris for a pod-style vape it was found to have infringed in a $95 million patent verdict nearly two years ago, pointing to a recent licensing deal it signed with Juul.

  • July 03, 2024

    Judge OKs Bid To End FindLaw Trade Secrets Lawsuit

    A New York federal judge has approved a deal to resolve a trade secrets dispute between West Publishing Corp. and RizeUp Media Inc. stemming from the departure of several key employees from West.

  • July 03, 2024

    Turf Co. Wants Out Of Rival's Trade Secrets Suit

    Facing allegations from a major artificial turf manufacturer that it poached one of its executives and trade secrets, a rival turf company hit back Tuesday by claiming that it has "no idea what information might be encompassed" by allegedly stolen files, and thus, the suit must be dismissed.

  • July 03, 2024

    After Chevron Deference: What Lawyers Need To Know

    This term, the U.S. Supreme Court overturned Chevron deference, a precedent established 40 years ago that said when judges could defer to federal agencies' interpretations of law in rulemaking. Here, catch up with Law360's coverage of what is likely to happen next.

  • July 02, 2024

    Samsung Says IP Law Firm, Litigation Funder Misused Info

    Samsung Electronics Co. Ltd. says an intellectual property law firm and a Chinese litigation funder used its confidential information without permission to help Staton Techiya LLC assert patent infringement allegations, telling a Texas federal judge that the conduct demonstrated why the court should add the other companies to Samsung's suit.

  • July 02, 2024

    Ex-Jets Worker Says Team, NFL Stole His Logo Design

    A former New York Jets film and video director claims the team used his logo design off and on for years without his permission or compensating him for its use, according to a suit filed in federal court.

  • July 02, 2024

    Mike Huckabee Says Meta Hosted Fake CBD Gummy Ads

    Former Arkansas Gov. Mike Huckabee says Meta Platforms Inc. has been allowing and hosting advertisements that falsely portray him promoting CBD gummies, leading to people falsely associating him with the CBD industry and marijuana use, according to a suit filed Monday in Delaware federal court.

  • July 02, 2024

    FTC Investigating Teva Inhaler Patent Listings, Report Says

    The Federal Trade Commission has opened an investigation into Teva Pharmaceuticals after it refused to remove inhaler patents from a key federal database, according to a Washington Post report citing confidential agency documents.

  • July 02, 2024

    Chamber, Pharma Slam Colorado Drug Price Controls

    The U.S. Chamber of Commerce and a prominent pharmaceutical industry group have urged a Colorado federal court to bar a state review board from setting price controls on prescription drugs, arguing that the practice is "irreconcilable" with federal patent law.

  • July 02, 2024

    'Shark Tank' Sweatshirt Biz Lands Injunction, But No Atty Fees

    The startup behind "The Comfy" sweatshirt featured in an episode of "Shark Tank" that won an $18 million verdict against a rival sweatshirt brand has secured an injunction against the competitor, but it has failed to collect nearly $2 million in requested legal fees on account of "quarrelsome conduct on both sides," according to an Arizona federal judge.

  • July 02, 2024

    Health Data Co. Alleges Contract Breach, Seeks Del. TRO

    A Blue Cross Blue Shield Association healthcare data licensee has sued for a Delaware Court of Chancery injunction that would bar a client from sharing a valuable database of BCBS medical and pharmacy claims with direct competitor Cigna Corp.

  • July 02, 2024

    USPTO Faces TM Suit From Ariana Grande Over Benefit Show

    Federal trademark officials wrongly turned down a bid by pop star Ariana Grande to register a trademark relating to a benefit concert she performed in England following the deadly bombing at one of her other shows in Manchester, according to a new lawsuit.

  • July 02, 2024

    Conn. Justices Send Trade Secrets Row Back To Trial Court

    The Connecticut Supreme Court ordered a "limited" new trial Tuesday in a trade secrets case that pit Dur-A-Flex Inc. against numerous companies tied to research chemist Samet Dy, its former employee, finding error in the lower court's rulings on issues including damages and the enforceability of Dy's noncompete agreement.

  • July 02, 2024

    Marriott Loses Counterclaim In Delta's TM Suit

    Delta Air Lines Inc. has won its fight against Marriott International Inc.'s claim that the airline breached an agreement over the use of "Delta Hotels," with a Georgia federal judge finding that the deal at issue applies only in Hong Kong and China.

  • July 02, 2024

    Justices Told Fed. Circ. Nullified Limits On PTAB Evidence

    Manufacturer Provisur Technologies Inc. has asked the U.S. Supreme Court to review a Federal Circuit decision reviving rival Weber Inc.'s challenge to Provisur's food slicer patents, saying the appellate court flouted precedent that limits the evidence available in Patent Trial and Appeal Board cases.

  • July 02, 2024

    Hytera Hit With Discovery Sanctions In Motorola Radio IP Suit

    An Illinois federal judge imposed sanctions against China's Hytera Communications on Monday for flouting three court orders to produce source code for review in Motorola's patent dispute claiming the radio manufacturer unlawfully copied its digital two-way radio technology and infringed seven patents.

Expert Analysis

  • How Echoing Techniques Can Derail Witnesses At Deposition

    Author Photo

    Before depositions, defense attorneys must prepare witnesses to recognize covert echoing techniques that may be used by opposing counsel to lower their defenses and elicit sensitive information — potentially leading to nuclear settlements and verdicts, say Bill Kanasky and Steve Wood at Courtroom Sciences.

  • Fed. Circ. In Feb.: Using Prior Products To Invalidate A Patent

    Author Photo

    The Federal Circuit's recent Weber v. Provisu ruling, that prior-product operating manuals constituted printed publications that can be used to invalidate patents in an inter partes review proceeding, makes it easier for a petitioner to invalidate a patent, say Sean Murray and Jeremiah Helm at Knobbe Martens.

  • How Cos. Can Assess Open-Source Contribution Patent Risks

    Author Photo

    Recent trends underscore the importance of open-source software to the technology industry for both engineering and strategic purposes, and companies should consider using a framework that addresses whether contributions require granting licenses to patent claims in portfolios to analyze associated risks, says Shrut Kirti at TAE Technologies.

  • 7 Common Myths About Lateral Partner Moves

    Author Photo

    As lateral recruiting remains a key factor for law firm growth, partners considering a lateral move should be aware of a few commonly held myths — some of which contain a kernel of truth, and some of which are flat out wrong, says Dave Maurer at Major Lindsey.

  • What's At Stake In Pending Fed. Circ. Design Patent Test Case

    Author Photo

    The full Federal Circuit recently heard argument in LKQ v. GM Global, a case concerning patent obviousness in the aftermarket for auto parts; the court's decision will likely influence how design patents are obtained, enforced and challenged, and affect the broader innovation ecosystem, says Larry DeMeo at Hunton.

  • No AI FRAUD Act Is A Significant Step For Right Of Publicity

    Author Photo

    The No Artificial Intelligence Fake Replicas and Unauthorized Duplications Act's proposed federal right of publicity protection, including post-mortem rights, represents a significant step toward harmonizing the landscape of right of publicity law, Rachel Hofstatter and Aaron Rosenthal at Honigman.

  • Series

    Cheering In The NFL Makes Me A Better Lawyer

    Author Photo

    Balancing my time between a BigLaw career and my role as an NFL cheerleader has taught me that pursuing your passions outside of work is not a distraction, but rather an opportunity to harness important skills that can positively affect how you approach work and view success in your career, says Rachel Schuster at Sheppard Mullin.

  • Averting Patent And Other IP Risks In Generative AI Use

    Author Photo

    While leveraging generative AI presents potential problems such as loss of ownership of patents and other intellectual properties, a series of practice tips, including ensuring that the technology is used as a supplementary tool and is not contributing to invention conception, can help mitigate those concerns, say Mackenzie Martin and Bryce Bailey at Baker McKenzie.

  • After TikTok, Tiptoeing Toward Patent Transfer Alignment

    Author Photo

    Following the Fifth Circuit's TikTok decision, which aimed to standardize transfer analysis in patent cases, the Federal Circuit and Texas federal courts facing transfer requests have taken small steps to consider the practical realities of patent litigation, reinforcing the intensely factual focus of the analysis, says Charles Fowler at McKool Smith.

  • New Hydrogen Regulations Show The Need For IP Protections

    Author Photo

    The introduction of hydrogen regulations, such as the IRS' proposed tax credit for clean hydrogen under the Inflation Reduction Act, are reshaping the competitive landscape, with intellectual property rights an area of increased emphasis, say Evan Glass and James De Vellis at Foley & Lardner.

  • Inside The PTAB's Seagen Cancer Drug Patent Decision

    Author Photo

    The Patent Trial and Appeal Board's recent finding that Seagen's claims for antibody-drug conjugate technology were unpatentable — for lack of enablement, lack of written description and anticipation — mark the latest chapter in the complex patent dispute as the case heads for director review, says Ryan Hagglund at Loeb & Loeb.

  • 6 Pointers For Attys To Build Trust, Credibility On Social Media

    Author Photo

    In an era of information overload, attorneys can use social media strategically — from making infographics to leveraging targeted advertising — to cut through the noise and establish a reputation among current and potential clients, says Marly Broudie at SocialEyes Communications.

  • Opinion

    Biden Admin's March-In Plan Would Hurt Medical Innovation

    Author Photo

    The Biden administration's proposal to reinterpret the Bayh-Dole Act and allow the government to claw back patents when it determines that a commercialized product's price is too high would discourage private investment in important research and development, says Ken Thorpe at the Rollins School of Public Health.

  • Google Patent Case Is A Claim Construction Litigation Lesson

    Author Photo

    The Federal Circuit's recent precedential decision in Google v. EcoFactor, which held that the Patent Trial and Appeal Board erred in the claim construction it had unknowingly adopted, shows that litigators should be alert to claim construction issues that masquerade as something else, says Roy Wepner at Kaplan Breyer.

  • A Post-Mortem Analysis Of Stroock's Demise

    Author Photo

    After the dissolution of 147-year-old firm Stroock late last year shook up the legal world, a post-mortem analysis of the data reveals a long list of warning signs preceding the firm’s collapse — and provides some insight into how other firms might avoid the same disastrous fate, says Craig Savitzky at Leopard Solutions.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!